Elixir's focal stress system to treat calcified lesions hits success in trial
Elixir reported high rates of clinical success with its LithiX Hertz Contact IVL system at EuroPCR 2024.
Source: yahoo.com
Elixir Medical News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Elixir Medical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Elixir Medical Today - Breaking & Trending Today
Elixir Medical Receives FDA Breakthrough Device Designation for DynamX BTK System for Below-The-Knee Arterial Disease
Elixir Medical has announced it has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its DynamX BTK System, a novel, adaptive implant for use in the treatment of narrowed or blocked vessels below-the-knee (BTK) in patients with chronic limb-threatening ischemia (CLTI). The company reports this broadens the use of the novel bioadaptor platform technology beyond the treatment of coronary artery disease.
Source: dicardiology.com
Drug-coated balloon shows superiority in coronary in-stent restenosis treatment
In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty.
Source: news-medical.net
Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis
This clinical trial compares a paclitaxel-coated balloon vs an uncoated balloon in patients with in-stent restenosis undergoing percutaneous coronary interventi
Source: jamanetwork.com
BIDMC-led trial leads to FDA approval of coronary drug-coated balloons
In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center
Source: newswise.com